Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Meningitis, Serogroup Y”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableStudy completedNCT01452438
What this trial is testing

Safety Surveillance of MenACWY-CRM Vaccine in Children

Who this might be right for
Meningococcal Disease
Novartis Vaccines 393
Not applicableStudy completedNCT01452464
What this trial is testing

Safety of MenACWY-CRM Vaccination in Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 55,397
Not applicableStudy completedNCT02500511
What this trial is testing

Persistence of Protective Antibody Titers 12-24 Months After NmVac4-A/C/Y/W-135-DT Vaccination: Follow Up Study

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 50
Early research (Phase 1)Study completedNCT04236960
What this trial is testing

Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.

Who this might be right for
Meningococcal Infections
Walvax Biotechnology Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT00962624
What this trial is testing

Study of Meningococcal B Vaccine and ACWY Conjugate Vaccine in Healthy Adults

Who this might be right for
Meningococcal Meningitis, Serogroup AMeningococcal Meningitis, Serogroup BMeningococcal Meningitis, Serogroup C+2 more
Prof. Elizabeth Miller 38
Testing effectiveness (Phase 2)Study completedNCT01897402
What this trial is testing

Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 525
Testing effectiveness (Phase 2)Study completedNCT00355121
What this trial is testing

Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

Who this might be right for
Meningococcal MeningitisTetanusDiphtheria+2 more
Sanofi 882
Testing effectiveness (Phase 2)Study completedNCT00771849
What this trial is testing

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 103
Testing effectiveness (Phase 2)Ended earlyNCT00772629
What this trial is testing

Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 18
Post-approval studies (Phase 4)Study completedNCT00119080
What this trial is testing

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

Who this might be right for
Meningitis
Centers for Disease Control and Prevention 4,000